We are live on ! Find out more
Neuberger Berman Group

Neuberger Berman Group Portfolio holdings

AUM $150B
1-Year Est. Return 40.08%
This Fund
S&P 500
This Quarter Est. Return
+3.72%
1 Year Est. Return
+40.08%
3 Year Est. Return
+113.08%
5 Year Est. Return
+141.06%
10 Year Est. Return
+565.4%
AUM
$134B
AUM Growth
-$2.51B
Cap. Flow
-$4.46B
Cap. Flow %
-3.32%
Top 10 Hldgs %
24%
Holding
2,213
New
182
Increased
966
Reduced
894
Closed
102
Avg Time Held Equity + Options
22.2 quarters
Top 10 Avg Time Held Equity + Options
23.8 quarters
Top 20 Avg Time Held Equity + Options
19 quarters
Avg Time Held Equity only
22.3 quarters
Top 10 Avg Time Held Equity only
23.8 quarters
Top 20 Avg Time Held Equity only
19 quarters

Top Sells

Rank Stock Value
1
SNDK icon
Sandisk
SNDK
+$246M
2
SPGI icon
S&P Global
SPGI
+$201M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$197M
4
AON icon
Aon
AON
+$184M
5
JPM icon
JPMorgan Chase
JPM
+$172M

Sector Composition

Rank Sector Weight
1 Technology 26.15%
2 Financials 14.23%
3 Industrials 11.32%
4 Healthcare 9.42%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CLNE icon
2076
Clean Energy Fuels
CLNE
$324M
$26K ﹤0.01%
12,378
+1,767
+17% +$4.32K
2025 Q2
2 quarters
EGHT icon
2077
8x8 Inc
EGHT
$305M
$26K ﹤0.01%
+13,178
New +$25.9K
2025 Q4
0 quarters
SATL icon
2078
Satellogic
SATL
$792M
$25.2K ﹤0.01%
+13,502
New +$29.2K
2025 Q4
0 quarters
FFAI
2079
Faraday Future Intelligent Electric
FFAI
$6.74M
$23.3K ﹤0.01%
+152
New +$28.2K
2025 Q4
0 quarters
BTBT icon
2080
Bit Digital
BTBT
$465M
$23.3K ﹤0.01%
+12,307
New +$35.6K
2025 Q4
0 quarters
EDIT icon
2081
Editas Medicine
EDIT
$445M
$22.4K ﹤0.01%
10,908
-1,089
-9% -$3.14K
2025 Q2
2 quarters
ALEC icon
2082
Alector
ALEC
$232M
$22.1K ﹤0.01%
+14,173
New +$25.1K
2025 Q4
0 quarters
LFT
2083
Lument Finance Trust
LFT
$27.2M
$22K ﹤0.01%
+1,561
New +$24.9K
2025 Q4
0 quarters
ONMD icon
2084
OneMedNet
ONMD
$25M
$21.5K ﹤0.01%
1,950
– –
2024 Q2
6 quarters
MNTK icon
2085
Montauk Renewables
MNTK
$360M
$20.9K ﹤0.01%
12,525
-2,097
-14% -$4.03K
2025 Q2
2 quarters
NKTX icon
2086
Nkarta
NKTX
$161M
$19K ﹤0.01%
+10,279
New +$20.5K
2025 Q4
0 quarters
TCRX icon
2087
TScan Therapeutics
TCRX
$16.1M
$18.4K ﹤0.01%
18,400
– –
2025 Q2
2 quarters
CHRS icon
2088
Coherus Oncology
CHRS
$165M
$18.4K ﹤0.01%
12,951
-4,157
-24% -$6.06K
2025 Q1
3 quarters
DDD icon
2089
3D Systems Corp
DDD
$562M
$18.1K ﹤0.01%
10,249
-5,930
-37% -$14.4K
2025 Q3
1 quarter
SABR icon
2090
Sabre
SABR
$767M
$17.7K ﹤0.01%
12,991
-2,560
-16% -$4.41K
2024 Q2
6 quarters
SKIN icon
2091
SkinHealth Systems
SKIN
$71.6M
$17K ﹤0.01%
+12,252
New +$17.7K
2025 Q4
0 quarters
ATYR icon
2092
aTyr Pharma
ATYR
$24.1M
$16K ﹤0.01%
+20,454
New +$16.8K
2025 Q4
0 quarters
FATE icon
2093
Fate Therapeutics
FATE
$261M
$13.7K ﹤0.01%
+13,950
New +$16.8K
2025 Q4
0 quarters
KOS icon
2094
Kosmos Energy
KOS
$1.57B
$13.5K ﹤0.01%
14,887
+798
+6% +$1.05K
2024 Q2
6 quarters
TEAD icon
2095
Teads Holding Co
TEAD
$53.3M
$11.4K ﹤0.01%
+16,175
New +$17.1K
2025 Q4
0 quarters
MYO icon
2096
Myomo
MYO
$56.6M
$10.1K ﹤0.01%
+11,136
New +$10.7K
2025 Q4
0 quarters
AGL icon
2097
Agilon Health
AGL
$1.38B
$8.95K ﹤0.01%
520
+34
+7% +$659
2025 Q3
1 quarter
MYPS icon
2098
PLAYSTUDIOS Inc
MYPS
$49.4M
$8.04K ﹤0.01%
1,235
+89
+8% +$693
2024 Q3
5 quarters
ENLV icon
2099
Enlivex Ltd
ENLV
$5.06M
$7.73K ﹤0.01%
733
– –
2025 Q1
3 quarters
TVGN icon
2100
Tevogen Inc
TVGN
$44.1M
$4.76K ﹤0.01%
+288
New +$7.49K
2025 Q4
0 quarters

Similar funds

Neuberger Berman Group's Q4 2025 Portfolio in Review

As of Q4 2025, Neuberger Berman Group held 2,213 positions worth $134B, down 1.8% from $137B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Neuberger Berman Group withdrew a net $4.46B in Q4 2025, closing 102 positions and reducing 894 holdings. Its most notable exit was Verona Pharma, an estimated $36M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.

Against the trend, Neuberger Berman Group opened a new position in BillionToOne Inc worth $57.4M.

  • Neuberger Berman Group's largest Q4 2025 buy was BillionToOne Inc: 700,867 shares worth $57.4M.
  • Neuberger Berman Group added most to Neuberger Core Equity ETF in Q4 2025, an estimated $190M increase.
  • Neuberger Berman Group's biggest Q4 2025 reduction was Sandisk, cutting an estimated $246M.
  • Neuberger Berman Group fully exited Verona Pharma in Q4 2025, selling an estimated $36M.
  • Neuberger Berman Group's ten largest holdings make up 24% of its $134B portfolio in Q4 2025.
  • Neuberger Berman Group opened 182 new positions and closed 102 in Q4 2025.
  • Neuberger Berman Group's portfolio value fell 1.8% quarter-over-quarter to $134B.

Based on Neuberger Berman Group's 13F filing for Q4 2025, filed 13 Feb 2026.